Health policy researchers are calling on the US Food and Drug Administration (FDA) to do more to strengthen its accelerated approval program for cancer drugs, including no longer approving drugs based ...
Guidance development and publication from the Food and Drug Administration (FDA) has long been considered an essential element of medical product development, approval, and regulation. While temporary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results